Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
- Palacios-Baena, Zaira Raquel
- Gutiérrez-Gutiérrez, Belén
- De Cueto, Marina
- Viale, Pierluigi
- Venditti, Mario
- Hernández-Torres, Alicia
- Oliver, Antonio
- Martínez-Martínez, Luis
- Calbo, Esther
- Pintado, Vicente
- Gasch, Oriol
- Almirante, Benito
- Antonio Lepe, José
- Pitout, Johann
- Akova, Murat
- Peña-Miralles, Carmen
- Schwaber, Mitchell J
- Tumbarello, Mario
- Tacconelli, Evelina
- Origüen, Julia
- Prim, Nuria
- Bou, German
- Giamarellou, Helen
- Bermejo, Joaquín
- Hamprecht, Axel
- Pérez, Federico
- Almela, Manuel
- Lowman, Warren
- Hsueh, Po-Ren
- Navarro-San Francisco, Carolina
- Torre-Cisneros, Julián
- Carmeli, Yehuda
- Bonomo, Robert A
- Paterson, David L
- Pascual, Álvaro
- Rodríguez-Baño, Jesús
DOIAbstract
Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality
Add to ORKG